Effect of Novel High Dissolving Transitional Foods
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT06522958
- Status
- Enrolling By Invitation
Conditions
- Craniofacial Surgery
Eligibility Criteria
- Sex
- ALL
- Age
- 6 Months - 18 Years
- Healthy Volunteers
- Not accepted
Interventions
- High Dissolving Transitional Food — DIETARY_SUPPLEMENTTransitional foods are solid foods that rapidly change texture in the presence of moisture (e.g., water or saliva) or temperature change. Duration of consumption of the investigational agent will include the time of the surgery until the second post-operative evaluation. This is estimated to be approximately 1-2 months in total.
Study Details
This is a prospective comparative study, where patients who meet inclusion criteria undergoing a craniofacial procedure will either be provided with novel high dissolving transitional foods for use in the post-operative period (Intervention Group) or will not be provided the food and will proceed as per current standard of care (Standard of Care Group). Both groups will be followed pre-operatively at time of pre-operative visit, and will be followed in the post-operative period, with two visits at 1 and 3 weeks post-operatively, respectively.
Key Dates
- Start date
- Aug 9, 2024
- Status verified
- Apr 2026
- Primary completion
- Feb 28, 2027
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Intervention GroupPatients randomized to the intervention group will receive a high dissolving transitional food product.
- No Intervention: Standard of Care GroupPatients randomized to the standard of care group will not receive a high dissolving transitional food product.
Primary Outcome Measure
Caregiver-Reported Rating of Feeding Experience [ Time Frame: Week 1 Post-Operation (Post-Op) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10017 | - |
Find similar trials in New York, NY
By research site